Xi'an Haorui Genomics Technology Co, Ltd

Established in 2019, Xi'an Haorui Genomics Technology Co., Ltd. is the first and largest third-generation sequencing platform in Western China. The company offers comprehensive long-read sequencing services spanning both scientific research and clinical applications.

In the research sector, Haorui Genomics supports a wide range of projects including whole-genome sequencing, transcriptome analysis, epigenetic research, and microbial genomics, serving universities and research institutions with high-quality data delivery.

In the clinical sector, the company develops and provides testing services for transplantation matching, blood transfusion safety, genetic disease screening, pharmacogenomic analysis, and oncology-related applications.

With extensive experience in both discovery-driven research and regulatory-compliant clinical testing, Haorui Genomics has established a full-chain service system from sample processing and library preparation to sequencing and bioinformatics analysis. The company has built the region's largest long-read sequencing database, generating over 300TB of data monthly, and maintains research partnerships with leading hospitals and institutions nationwide, demonstrating proven capability in delivering reliable genomic solutions across both discovery and diagnostics.